...
  • 主题
高级搜索  >
历史搜索 清空历史
首页> 外文期刊>Australasian Biotechnology >Developments in biotechnology law-gene technology act 2000
【24h】

Developments in biotechnology law-gene technology act 2000

机译：2000年生物技术法基因技术法的发展

获取原文
获取原文并翻译 | 示例
           
页面导航
  • 摘要
  • 著录项
  • 相似文献
  • 相关主题

摘要

Australia's recent adoption of a comprehensive regulatory regime to cover research into and use of genetically modified organisms (GMOs) has already resulted in some debate about disclosure requirements. The regime is established under the Gene Technology Act 2000 (the Act) and, since it came into force on 21 June 2001, some major industry participants have sought to avoid disclosure of the location of GM crop trials by having them classified as confidential. Companies involved in GM research are concerned that the disclosure requirements of the Act may jeopardise their research and endanger the properties of farmers who have agreed to conduct GM trials. The strict new regime is a response to growing concern about public safety issues arising fromthe increased use of GMO's in the fields of research, agriculture and industry. There was concern that these issues were not being addressed by the previous voluntary guidelines. The following is a summary of the scope of the new regime and the key issues that researchers and investors in the GM industry should to be aware of.
机译：澳大利亚最近采用了全面的监管制度来涵盖对转基因生物（GMOs）的研究和使用，已经引起了有关公开要求的争论。该制度是根据《 2000年基因技术法》（该法）建立的，自2001年6月21日生效以来，一些主要行业参与者试图通过将它们归类为机密来避免披露转基因作物试验的地点。参与转基因研究的公司担心，该法的披露要求可能会危害其研究，并危及已同意进行转基因试验的农民的财产。严格的新制度是对在研究，农业和工业领域中越来越多地使用转基因生物引起的对公共安全问题的日益关注的回应。有人担心以前的自愿准则没有解决这些问题。以下总结了新制度的范围以及转基因行业研究人员和投资者应注意的关键问题。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱：kefu@zhangqiaokeyan.com

京公网安备：11010802029741号 ICP备案号：京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有

  • 客服微信

  • 服务号